Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 24;5(2):e15.
doi: 10.2196/ijmr.5479.

Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in Japan

Affiliations

Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in Japan

Hidenori Kashihara et al. Interact J Med Res. .

Abstract

Background: Although the safety and effectiveness of stem cell therapies are yet to be proven, recent studies show that such therapies are being advertised with some questionable marketing techniques to effect positive portrayal of the therapies on the webpages of private-practice clinics to sell their therapies worldwide. In such context, those clinics communicate directly with consumers (patients and their family members) via the clinics' websites. Meanwhile, the Health Science Council at the Ministry of Health, Labour, and Welfare (MHLW) in Japan has pointed out noncompliance of some local clinics with the provisions concerning medical advertising in the Medical Care Act in the past. However, locally little is known about the current status of those clinics including the quality of their webpage information disseminated.

Objective: To evaluate the quality of website information of private-practice clinics offering cell therapies in Japan.

Methods: Twenty-four websites with 77 treatments from the Google search were identified for evaluation. The following three exploratory analyses were performed: first in order to ascertain web-based portrayal of private-practice clinics offering cell therapies, a descriptive analysis was conducted using a coding frame; second we evaluated the quality of the target website information from the viewpoint of the level of consideration taken for patients and their family members, using 10 quality criteria ("the Minimum Standard") from the e-Health Code of Ethics 2.0; third we counted and coded expressions that matched set categories for "name-dropping" and "personalized medicine" in the information posted on these websites.

Results: Analysis on the treatments (N=77) revealed 126 indications (multiple response): the top three indications were "cancer," "skin-rejuvenation/antiaging/anti-skin aging," and "breast augmentation/buttock augmentation." As for the portrayal of treatment risks and benefits, 78% (60/77) of treatments were mentioned with "benefits," whereas 77% (59/77) of treatments were mentioned with "risks." As for the source(s) cited for the discussions of treatment risks and benefits, no treatment quoted an expert's opinion for the risks, whereas 7% (6/77) treatments quoted external sources for the benefits. As for the results with e-Health Code of Ethics 2.0, not a single clinic fulfilled all the 10 criteria; 63% (15/24) of the clinics was found exercising "name-dropping," and 21% (5/24) of the clinics mentioned expressions related to "personalized medicine" on their websites.

Conclusions: Our website content analyses confirmed the following: (1) the clinics mentioned the risks or benefits of the treatments with hardly any scientific citations, (2) the way the website information was disseminated was inappropriate for patients and their families, and (3) many websites seemed to be using marketing techniques in order to draw patients' interests or attentions. It is important that more similar studies are undertaken globally to enable an orchestrated regulatory approach toward private-practice clinics.

Keywords: descriptive analysis; direct-to-consumer; health information; medical tourism; misrepresentation; online marketing; regenerative medicine; regulations; stem cell; web survey.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Reviewed Websites (n=24) and their Compliance with e-health Code of Ethics 2.0. E1 Disclosure of information about the website operator; E2 Disclosure of information about sponsorship; E3 Provision of contact center for further enquiries; E4 Clarifying intended recipients of content; E5 Disclosure of the information concerning writing, production, and/or editorial supervision of conduct; E6 Adherence to relevant laws and regulations; E7 Notification to the users of profit-oriented activities on the websites; E8 Displaying a pop-up message box that reminds the user of being transferred to external websites when clicking the links to external websites; E9 Displaying the handling of personal information; E10 Displaying a privacy protection policy.

References

    1. Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med. 2012;10:133. doi: 10.1186/1741-7015-10-133. http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-10-133 1741-7015-10-133 - DOI - DOI - PMC - PubMed
    1. Braude P, Minger SL, Warwick RM. Stem cell therapy: hope or hype? BMJ. 2005 May 21;330(7501):1159–60. doi: 10.1136/bmj.330.7501.1159. http://europepmc.org/abstract/MED/15905229 330/7501/1159 - DOI - PMC - PubMed
    1. Taylor PL, Barker RA, Blume KG, Cattaneo E, Colman A, Deng H, Edgar H, Fox IJ, Gerstle C, Goldstein Lawrence S B. High KA, Lyall A, Parkman R, Pitossi FJ, Prentice ED, Rooke HM, Sipp DA, Srivastava A, Stayn S, Steinberg GK, Wagers AJ, Weissman IL. Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell. 2010 Jul 2;7(1):43–9. doi: 10.1016/j.stem.2010.06.001. http://linkinghub.elsevier.com/retrieve/pii/S1934-5909(10)00283-3 S1934-5909(10)00283-3 - DOI - PubMed
    1. Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell. 2008 Dec 4;3(6):591–4. doi: 10.1016/j.stem.2008.11.001. http://linkinghub.elsevier.com/retrieve/pii/S1934-5909(08)00573-0 S1934-5909(08)00573-0 - DOI - PubMed
    1. Ryan KA, Sanders AN, Wang DD, Levine AD. Tracking the rise of stem cell tourism. Regen Med. 2010 Jan;5(1):27–33. doi: 10.2217/rme.09.70. - DOI - PubMed